Market Newsdesk

February 17, 2021 9:33 pm

Veru Announces Pricing of Public Offering of Common Stock

MIAMI, Feb. 17, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, announced today the pricing of an underwritten public offering of 6,451,613 shares of its common stock at a price to the public of $15.50 per share. The gross proceeds to Veru from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $100 million. In addition, Veru has granted the underwriters a 30-day option to purchase up to an additional 967,741 shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about February 22, 2021, subject to the satisfaction of customary closing conditions.

Jefferies is acting as the sole book-running manager for the offering, Cantor and Oppenheimer & Co. are acting as lead managers for the offering, and H.C. Wainwright & Co. and Brookline Capital Markets, a division of Arcadia Securities, LLC are acting as co-managers for the offering.

Veru intends to use the net proceeds of the offering for research and development, clinical trial, regulatory, and sales and marketing expenditures, and for working capital and other general corporate purposes.

The offering is being made by Veru pursuant to a shelf registration statement on Form S-3 previously filed with the Securities and Exchange Commission (SEC) on June 26, 2020 and declared effective by the SEC on July 1, 2020. The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement and accompanying prospectus related to the offering will be filed with the SEC and will be available on the website of the SEC at www.sec.gov. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022, by telephone at (877) 821-7388 or by e-mail at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Veru Inc.

Veru Inc. is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer.

Cautionary Statement on Forward-Looking Statements

This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements in this press release
can be identified by the use of forward-looking words or phrases such as “anticipate,” “believe,” “could,” “expect, ” “intend,” “may,” “opportunity,” “plan,” “predict,” “potential,” “estimate,” “should, ” “will,” “would” or the negative of these terms or other words of similar meaning
.
Any forward-looking statements in this press release are based upon current plans and strategies of Veru Inc. (the Company) and reflect the Company’s current assessment of the risks and uncertainties related to its business and are made as of the date of this press release. The Company assumes no obligation to update any forward-looking statements contained in this press release because of new information or future events, developments or circumstances. Such forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and if any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our actual results could differ materially from those expressed or implied by such statements. Factors that may cause actual results to differ materially from those contemplated by such forward-looking statements include, but are not limited to, uncertainties related to market conditions and the satisfaction of customary closing conditions related to the public offering and the Company’s expectations regarding the completion, timing and size of the public offering and the use of proceeds therefrom. This list is not exhaustive and other risks are detailed in the Company’s periodic reports filed with the SEC, including the Company’s Form 10-K for the year ended September 30, 2020 and subsequent quarterly reports on Form 10-Q, which are available at www.sec.gov.

Contact:
Sam Fisch	800-972-0538
Director of Investor Relations

February 17, 2021 9:19 pm

JT CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Jianpu Technology, Inc. (JT)

JT CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Jianpu Technology, Inc. (JT)

LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York captioned Guttentag v.Jianpu Technology Inc., et al., (Case No. 1:21-cv-01419) on behalf of persons and entities that purchased or otherwise acquired Jianpu Technology, Inc. (“Jianpu” or the “Company”) (NYSE: JT) American Depositary Shares (“ADSs” or “shares”) between May 29, 2018 and February 16, 2021, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Investors are hereby notified that they have until 60 days from this notice to move the Court to serve as lead plaintiff in this action.

If you suffered a loss on your Jianpu investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at https://www.glancylaw.com/cases/jianpu-technology-inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] or visit our website at www.glancylaw.com to learn more about your rights.

On February 16, 2021, Jianpu announced the results of its review into “transactions carried out by the Credit Card Recommendation Business Unit” with third-party business entities. The Company concluded that previously reported revenue and associated expenses had been inflated due to “certain transactions [that] involved third-party agents (including both upstream agents and downstream suppliers) with undisclosed relationships and some transactions [that] lacked business substance.” Jianpu stated that it “anticipates the total amount of overstated revenue for the fiscal years 2018 and 2019 to be approximately, RMB 90 million and RMB 164 million, respectively, representing approximately 4.5% and 10.1% of the total revenue previously reported.”

On this news, the Company’s share price fell $0.60, or 13%, to close at $3.94 per share on February 16, 2021, on unusually heavy trading volume.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that certain of the Company’s transactions carried out by the Credit Card Recommendation Business Unit involved undisclosed relationships or lacked business substance; (2) that, as a result, Jianpu’s revenue and costs and expenses for fiscal 2018 and 2019 were overstated; (3) that there were material weaknesses in Jianpu’s internal control over financial reporting; (4) that, as a result of the foregoing, the Company’s fiscal 2018 Form 20-F was reasonably likely to be restated; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

If you purchased or otherwise acquired the Jianpu ADSs during the Class Period, you may move the Court no later than 60 days from this notice ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217006072/en/

Glancy Prongay & Murray LLP, Los Angeles

Charles H. Linehan, 310-201-9150 or 888-773-9224

1925 Century Park East, Suite 2100

Los Angeles, CA 90067

www.glancylaw.com

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo

February 17, 2021 9:18 pm

PEN INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Penumbra, Inc.

PR Newswire

NEW YORK, Feb. 17, 2021 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Penumbra, Inc. (“Penumbra” or the “Company”) (NYSE: PEN) from August 3, 2020 through December 15, 2020 (the “Class Period”). The lawsuit filed in the United States District for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased Penumbra securities, and/or would like to discuss your legal rights and options please visit Penumbra Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

The complaint alleges that during the Class Period defendants made false and/or misleading statements and/or failed to disclose: (1) that the Jet 7 Xtra Flex had known design defects that made it unsafe for its normal use; (2) that Penumbra did not adequately address the risk of the Jet 7 Xtra Flex causing serious injury and deaths, which had in fact already occurred; (3) that the Jet 7 Xtra Flex was likely to be recalled due to its safety issues; and (4) as a result, Penumbra’s public statements were materially false and misleading at all relevant times.

On December 8, 2020, Quintessential Capital Management (“QCM”) published a report questioning the validity and independence of the scientific research supporting the Jet 7 Xtra Flex’s safety, and accused the Company of using a fake author to publish studies regarding the purported safety and efficacy of its products.

In response, Penumbra’s stock price fell by 9%, $224.02 per share on December 7, 2020, to $204.70 per share on December 8, 2020, a decline of $19.95 per share.

On December 15, 2020, after the markets closed, the Company issued a press release announcing that it was issuing an “urgent” recall of the Jet 7 Xtra Flex because the catheter “may become susceptible to distal tip damage during use” which could lead to injury or death. On a conference call held the same day, the Company’s CEO acknowledged that the product’s design “ma[de] the catheter susceptible to failure in certain scenarios” and that the Company’s “steps to ensure the safe use of the product…were not able to fully address the risks.”

In response, Penumbra’s stock price fell by 7%, from $188.82 per share on December 15, 2020 to $174.98 per share on December 16, 2020, a decline of $13.84 per share.

If you wish to serve as lead plaintiff, you must move the Court no later than March 16, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Penumbra securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/penumbrainc-pen-shareholder-class-action-lawsuit-fraud-stock-345/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2021 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

View original content to download multimedia:http://www.prnewswire.com/news-releases/pen-investor-filing-deadline-bernstein-liebhard-llp-reminds-investors-of-the-deadline-to-file-a-lead-plaintiff-motion-in-a-securities-class-action-lawsuit-against-penumbra-inc-301230487.html

SOURCE Bernstein Liebhard LLP

February 17, 2021 9:13 pm

Mitsubishi Electric to Expand Product Range of Ku-band GaN HEMTs

Mitsubishi Electric to Expand Product Range of Ku-band GaN HEMTs

For multi- & single-carrier communications, larger data capacity and smaller SATCOM earth stations

TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that two new 13.75–14.5 GHz (Ku-band) 30W (45.3dBm) gallium-nitride high-electron-mobility transistors (GaN HEMTs) will be added to the company’s GaN HEMT lineup for satellite-communication (SATCOM) earth stations. The two products, one for multi-carrier¹ communication and the other for single-carrier² communication, will support increased data-transmission capacity and smaller earth stations. Sales will begin on March 15.

¹ Voice, video and data communication method that uses carrier signals of various frequencies

² Communication method that uses a single-frequency carrier signal

Ku-band satellite systems are increasingly being deployed for emergency communication during natural disasters and for satellite news gathering (SNG) by TV broadcasters in remote areas where cable networks do not exist. Meanwhile, in addition to the growing use of conventional single-carrier communication, multi-carrier communication is increasingly needed for fast, high-volume communication and to support the downsizing of mobile stations for purposes such as SNG.

So far, Mitsubishi Electric has introduced five GaN HEMTs for multi-carrier and single-carrier SATCOM earth stations. The two new 30W GaN HEMTs will enable more flexible amplifier designs, including for rated power levels and the use of GaN drivers. They also will support the downsizing of earth stations as well as faster, larger-capacity satellite communication.

For the full text, please visit: www.MitsubishiElectric.com/news/

View source version on businesswire.com: https://www.businesswire.com/news/home/20210217005343/en/

Customer Inquiries

Semiconductor & Device Marketing Div.B

Mitsubishi Electric Corporation

http://www.MitsubishiElectric.com/semiconductors/

Media Inquiries

Takeyoshi Komatsu

Public Relations Division

Mitsubishi Electric Corporation

Tel +81-3-3218-2346

[email protected]

http://www.MitsubishiElectric.com/news/

KEYWORDS: Japan Asia Pacific

INDUSTRY KEYWORDS: Semiconductor Technology Satellite Mobile/Wireless Telecommunications Hardware

MEDIA:

Logo

February 17, 2021 8:55 pm

IRTC SHAREHOLDER FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against iRhythm Technologies, Inc.

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of iRhythm Technologies, Inc. (“iRhythm” or the “Company”) (NASDAQ: IRTC) from August 4, 2020 and January 28, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of California alleges violations of the Securities Exchange Act of 1934.

If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit iRhythm Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements, as well as failed to disclose to investors that: (1) iRhythm’s business would suffer as a result of the CMS’ rulemaking; (2) reimbursement rates would in fact plummet; (3) a lack of national pricing in the CMS rule and fee schedule would cause uncertainty and weakness in the Company’s business; and (4) as a result of the foregoing, Defendants’ public statements were materially false and misleading at all relevant times.

The truth began to be revealed on December 1, 2020, when the CMS issued its final rule, which finalized the codes as anticipated, but did not finalize national pricing for certain products and services offered by iRhythm. Shares opened on December 2, 2020 at $183.00 each, down from the December 1, 2020, close of $240.64 per share.

Then on January 29, 2021, Medicare Administrative Contractor Novitas Solutions published actual reimbursement rates under the CMS’ 2021 Medicare Physician Fee Schedule. A Baird analyst commented that these rates were “way lower than” the former codes, citing one example where iRhythm was previously reimbursed around $311, but was now receiving just $42.68.

On this news, the price of iRhythm common stock closed at $168.42, down approximately 33% from its January 28, 2021 close of $251.00.

If you wish to serve as lead plaintiff, you must move the Court no later than April 2, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased iRhythm securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/irhythmtechnologiesinc-irtc-shareholder-class-action-lawsuit-stock-fraud-359/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

February 17, 2021 8:44 pm

Calumet Specialty Products Partners, L.P. to Release Fourth Quarter and Full Year 2020 Results on March 3, 2021

PR Newswire

INDIANAPOLIS, Feb. 17, 2021 /PRNewswire/ — Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the “Partnership,” “Calumet,” “we,” “our” or “us”) announced today that it plans to report results for the fiscal fourth quarter and full year 2020 on March 3, 2021. A conference call to discuss the financial and operational results is scheduled for March 3, 2021 at 9:00 AM ET.

Investors, analysts and members of the media interested in listening to the live presentation are encouraged to join a webcast of the call with accompanying presentation slides, available on the Partnership’s website at https://edge.media-server.com/mmc/p/sbme35te. Interested parties may also participate in the call by dialing (866) 584-9671 and entering the conference ID 7786751. A replay of the conference call will be available a few hours after the event on the investor relations section of the Company’s website, under the events section.

About Calumet Specialty Products Partners, L.P.
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is a master limited partnership and a leading independent producer of high-quality, specialty hydrocarbon products in North America. Calumet processes crude oil and other feedstocks into customized lubricating oils, solvents and waxes used in consumer, industrial and automotive products; produces fuel products including gasoline, diesel and jet fuel. Calumet is based in Indianapolis, Indiana, and operates nine manufacturing facilities located in northwest Louisiana, northern Montana, western Pennsylvania, Texas and eastern Missouri.

View original content:http://www.prnewswire.com/news-releases/calumet-specialty-products-partners-lp-to-release-fourth-quarter-and-full-year-2020-results-on-march-3-2021-301230507.html

SOURCE Calumet Specialty Products Partners, L.P.

February 17, 2021 8:43 pm

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages CD Projekt S.A. Investors with Large Losses to Secure Counsel Before Important February 22 Deadline in Securities Class Action First Filed by the Firm – OTGLY, OTGLF

PR Newswire

NEW YORK, Feb. 17, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of CD Projekt S.A. (OTC: OTGLY, OTGLF) between January 16, 2020 and December 17, 2020, inclusive (the “Class Period”), of the important February 22, 2021 lead plaintiff deadline.

SO WHAT: If you purchased CD Projekt securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the CD Projekt class action, go to http://www.rosenlegal.com/cases-register-2010.html http://www.rosenlegal.com/cases-register-1961.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 22, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience or resources. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020 founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Cyberpunk 2077 was virtually unplayable on the current-generation Xbox or PlayStation systems due to an enormous number of bugs; (2) as a result, Sony would remove Cyberpunk 2077 from the PlayStation store, and Sony, Microsoft and CD Projekt would be forced to offer full refunds for the game; (3) consequently, CD Projekt would suffer reputational and pecuniary harm; and (4) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the CD Projekt class action, go to http://www.rosenlegal.com/cases-register-2010.html http://www.rosenlegal.com/cases-register-1961.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/rosen-recognized-investor-counsel-encourages-cd-projekt-sa-investors-with-large-losses-to-secure-counsel-before-important-february-22-deadline-in-securities-class-action-first-filed-by-the-firm–otgly-otglf-301230480.html

SOURCE Rosen Law Firm, P.A.

February 17, 2021 8:40 pm

FinServ Acquisition Corp. II Announces Pricing of Upsized $265,000,000 Initial Public Offering

New York, NY, Feb. 17, 2021 (GLOBE NEWSWIRE) — FinServ Acquisition Corp. II (the “Company”) announced today that it priced its upsized initial public offering of 26,500,000 units at $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and will begin trading tomorrow, Thursday, February 18, 2021, under the ticker symbol “FSRXU”. Each unit consists of one of the Company’s shares of Class A common stock and one-quarter of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “FSRX” and “FSRXW,” respectively. The offering is expected to close on February 22, 2021, subject to customary closing conditions.

The Company is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on businesses in the financial technology (“FinTech”) and financial services industries. The Company is led by Lee Einbinder, Chief Executive Officer, Howard Kurz, President, and Steven Handwerker, Chief Financial Officer.

Citigroup Global Markets Inc. and Barclays Capital Inc. are acting as joint book running managers for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,975,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from Citigroup Global Markets Inc., 388 Greenwich Street, New York, NY, 10013, Attn: General Counsel, fax no.: (646) 291-1469, and from Barclays Capital Inc., 745 Seventh Avenue, New York, NY, 10019, Attn: Syndicate Registration, fax no.: (646) 834-8133.

Registration statements relating to these securities have been filed with the Securities and Exchange Commission (the “SEC”) and became effective on February 17, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

FORWARD-LOOKING STATEMENTS

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and the anticipated use of the net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

Lee Einbinder
Chief Executive Officer
FinServ Acquisition Corp. II
[email protected]

February 17, 2021 8:35 pm

BTBT SHAREHOLDER DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against Bit Digital, Inc.

NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Bit Digital, Inc. (“Bit Digital” or the “Company”) (NASDAQ: BTBT) from December 21, 2020 through January 8, 2021 (the “Class Period”). The lawsuit filed in the United States District Court for the Southern District of New York alleges violations of the Securities Exchange Act of 1934.

If you purchased Bit Digital securities, and/or would like to discuss your legal rights and options please visit Bit Digital Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that the Defendants made false and/or misleading statements and/or failed to disclose that: (1) Bit Digital overstated the extent of its bitcoin mining operation; (2) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

On January 11, 2021, J Capital Research issued a research report alleging, among other things, that Bit Digital operates “a fake crypto currency business” “designed to deal funds from investors.” While the Company claims “it was operating 22,869 bitcoin miners in China,” J Capital’s report alleged that “is simply not possible” and stated that “[w]e verified with local governments supposedly hosting the BTBT mining operation that there are no bitcoin miners there.”

On this news, the Bit Digital’s stock price fell $6.27, or approximately 25%, to close at $18.76 per share on January 11, 2021.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Bit Digital securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/bitdigital-btbt-shareholder-class-action-lawsuit-fraud-stock-357/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Contact Information

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

February 17, 2021 8:33 pm

BREAKING NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages GTT Communications, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by Firm – GTT

PR Newswire

NEW YORK, Feb. 17, 2021 /PRNewswire/ —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of GTT Communications, Inc. (NYSE: GTT) between May 5, 2016 and November 9, 2020, inclusive (the “Class Period”), of the important March 15, 2021 lead plaintiff deadline in the securities class action first filed by the firm.

SO WHAT: If you purchased GTT securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the GTT class action, go to http://www.rosenlegal.com/cases-register-1927.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 15, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

DETAILS OF THE CASE: The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) GTT’s internal controls suffered from issues related to the recording and reporting of Cost of Telecommunications Services; (2) GTT’s previously reported Cost of Telecommunications was inaccurate or accounted for unsupported adjustments; (3) inadequate internal controls would result in delays in GTT’s 10-Q quarterly reports; and (4) as a result of the foregoing, defendants’ public statements were materially false and/or misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the GTT class action, go to http://www.rosenlegal.com/cases-register-1927.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 40th Floor
      New York, NY 10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      [email protected]
      [email protected]
      [email protected]
      www.rosenlegal.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/breaking-notice-rosen-a-top-ranked-law-firm-encourages-gtt-communications-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action-first-filed-by-firm–gtt-301230454.html

SOURCE Rosen Law Firm, P.A.